me/cfs

  1. forestglip

    Hypothesis How I treat my patients with Myalgic Encephalomyelitis, Chronic Fatigue Syndrome (ME/CVS), fibromyalgia or “long COVID”, 2025, Comhaire

    How I treat my patients with Myalgic Encephalomyelitis, Chronic Fatigue Syndrome (ME/CVS), fibromyalgia or “long COVID” Frank Comhaire Abstract Common to Myalgic encephalomyelitis, chronic fatigue syndrome and so-called long Covid is the panoply of complaints, with Post Exertional Malaise...
  2. J

    Housing project for severely ME/CFS sufferers in Neunkirchen-Seelscheid, Germany: Interested parties wanted!

    A housing project specifically for people with severe ME/CFS, including 24-hour assistance, is being planned in Neunkirchen-Seelscheid . A developer, in collaboration with Sozialhummel, plans to build barrier-free apartments in 53819 Neunkirchen-Seelscheid that are optimally tailored to the...
  3. Nightsong

    Identifying commonalities and differences between EHR representations of PASC and ME/CFS in the RECOVER EHR cohort, 2025, Powers et al

    Abstract: Background Shared symptoms and biological abnormalities between post-acute sequelae of SARS-CoV-2 infection (PASC) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) could suggest common pathophysiological bases and would support coordinated treatment efforts. Empirical...
  4. forestglip

    Concentrations of Uremic Bacterial Metabolites in Patients with Post-COVID-19 Syndrome, 2025, Brigo et al

    Concentrations of Uremic Bacterial Metabolites in Patients with Post-COVID-19 Syndrome Natascha Brigo, Wolfram Mayr, Maja Taenzer, Judith Löffler-Ragg, Andrea Schroll, Sabine Engl, Burkhard Schütz, Peter Rappl, Till Heine, Guenter Weiss, Katharina Kurz [Line breaks added] Abstract...
  5. forestglip

    Preprint [...] Plasmapheresis in [ME/CFS] Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies – a Pilot Study, 2025, Oesch-Régeni et al

    Effect on Quality of Life of Therapeutic Plasmapheresis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies – a Pilot Study Boglárka Oesch-Régeni, Nicolas Germann, Georg Hafer, Dagmar Schmid, Norbert Arn [Line breaks...
  6. Wyva

    Understanding symptom clusters, diagnosis and healthcare experiences in ME/CFS and long COVID: a cross-sectional survey in the UK, 2025, Mansoubi et

    Full title: Understanding symptom clusters, diagnosis and healthcare experiences in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID: a cross-sectional survey in the UK Maedeh Mansoubi, Thomas Richards, Martine Ainsworth-Wells, Russell Fleming, Phaedra Leveridge, Charles...
  7. Nightsong

    The PACE Trial’s GET Manual for Therapists Exposes the Fixed Incremental Nature of Graded Exercise Therapy for ME/CFS, 2025, Vink et al

    Abstract The British National Institute for Health and Care Excellence (NICE) published its updated guidelines for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in October 2021. NICE concluded, after an extensive review of the literature, that graded exercise therapy (GET) is...
  8. J

    Review Predisposing and Precipitating Factors in Epstein–Barr Virus-Caused ME/CFS, 2025, Leonard Jason

    Full title: Predisposing and Precipitating Factors in Epstein–Barr Virus-Caused Myalgic Encephalomyelitis/Chronic Fatigue Syndrome https://www.mdpi.com/2076-2607/13/4/702 Abstract Long COVID following SARS-CoV-2 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) following...
  9. forestglip

    Cytokine signature associated with disease severity in chronic fatigue syndrome patients, 2017, Montoya et al

    Cytokine signature associated with disease severity in chronic fatigue syndrome patients Jose G Montoya, Tyson H Holmes, Jill N Anderson, Holden T Maecker, Yael Rosenberg-Hasson, Ian J Valencia, Lily Chu, Jarred W Younger, Cristina M Tato, Mark M Davis Published: July 31, 2017 [Line breaks...
  10. ME/CFS Skeptic

    Association between pre-existing chronic conditions and severity of first SARS-CoV-2 infection symptoms among adults living in Canada, 2025, Cheta et

    Abstract Background: Individuals living with chronic conditions (CC) typically have a higher risk of more severe outcomes when exposed to infection. Although many studies have investigated the relationship between CCs and COVID-19 severity, they are generally limited to clinical or hospitalized...
  11. Nightsong

    Health-related quality of life in [ME/CFS] and [PCC]: a systematic review, 2025, Weigel+

    Abstract: Purpose Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post COVID-19 Condition (PCC) are debilitating, chronic multi-systemic illnesses that require multidisciplinary care. However, people with ME/CFS (pwME/CFS) and people with PCC (pwPCC) are often precluded from...
  12. forestglip

    Review Advocating the role of trained immunity in the pathogenesis of ME/CFS; a mini review, 2025, Humer et al

    Advocating the role of trained immunity in the pathogenesis of ME/CFS; a mini review Bart Humer, Willem A. Dik, Marjan A. Versnel [Line breaks added] Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic disease of which the underlying (molecular)...
  13. forestglip

    mtDNA deletion [...] with < 10 % heteroplasmy in muscle and isolated complex-V dysfunction misinterpreted as [CFS] over 21-years, 2025, Finsterer+

    mtDNA deletion m.8753_16566 with < 10 % heteroplasmy in muscle and isolated complex-V dysfunction misinterpreted as chronic fatigue syndrome over 21-years Josef Finsterer, Ana C. Fiorini, Fulvio A. Scorza, Carla A. Scorza [No abstract] Link | PDF (Clinics) [Open Access]
  14. Nightsong

    Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in [ME/CFS], 2025, Baraniuk

    Abstract: We proposed that cerebrospinal fluid would provide objective evidence for disrupted brain metabolism in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS). The concept of postexertional malaise (PEM) with disabling symptom exacerbation after limited exertion that does not...
  15. forestglip

    Review Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with [ME/CFS], 2025, Campenhout et al

    Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Jente Van Campenhout, Yanthe Buntinx, Huan-Yu Xiong, Arne Wyns, Andrea Polli, Jo Nijs, Joeri L. Aerts, Thessa Laeremans, Jolien Hendrix...
  16. forestglip

    Efficacy of Vitamin D Replacement Therapy on 28 Cases of [ME/CFS] After COVID-19 Vaccination, 2025, Kodama et al

    Efficacy of Vitamin D Replacement Therapy on 28 Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After COVID-19 Vaccination Shinichiro Kodama, Nafuko Konishi, Yuriko Hirai, Akinori Fujisawa, Mitsuko Nakata, Satoshi Teramukai, Masanori Fukushima Background Prolonged symptoms have...
  17. forestglip

    Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis, 2025, Sebaiti et al

    Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis Mehdi Aoun Sebaiti, Nadia Oubaya, Yannick Gounden, Chloé Samson, Emmanuele Lechapt, Abir Wahab, Alain Creange, Mathieu Hainselin, François-Jérôme Authier Objective...
  18. T

    HSE Clinical Practice Guidelines for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (Ireland)

    I thought it could be worth setting up a separate thread on this. These guidelines are separate to the NICE guidelines. Here's some background information from the ME Advocates Ireland website: https://meadvocatesireland.blogspot.com/2022/09/news-from-hse-re-clinical-guideline-for.html The...
  19. Wyva

    A comparison of genome-wide association analyses of persistent symptoms after Lyme disease, fibromyalgia, and ME/CFS, 2025, Hirsch et al

    Full title: A comparison of genome-wide association analyses of persistent symptoms after Lyme disease, fibromyalgia, and myalgic encephalomyelitis – chronic fatigue syndrome Annemarie G. Hirsch, Anne E. Justice, Amy Poissant, Cara M. Nordberg, Navya S. Josyula, John Aucott, Alison W. Rebman &...
  20. Nightsong

    Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Aetiology and Potential Treatments, 2025, Bansal+

    Abstract Systemic infection and inflammation impair mental function through a combination of altered attention and cognition. Here, we comprehensively review the relevant literature and report personal clinical observations to discuss the relationship between infection, peripheral inflammation...
Back
Top